Highsky Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -18.83%
(FY 2021)
- Profit 29.13%
(FY 2021)
- Ebitda 20.77%
(FY 2021)
- Net Worth -23.42%
(FY 2021)
- Total Assets -3.36%
(FY 2021)
About Highsky Medicare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Perdeep Singhal and Sudhir Singal serve as directors at the Company.
- CIN/LLPIN
U24304HR2017PTC068386
- Company No.
068386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Highsky Medicare Private Limited offer?
Highsky Medicare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Dietary Supplements, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Pharma & Bioanalytical Services.
Who are the key members and board of directors at Highsky Medicare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Perdeep Singhal  | Director | 15-Sep-2020 | Current |
| Sudhir Singal | Director | 15-Sep-2020 | Current |
Financial Performance of Highsky Medicare.
Highsky Medicare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.83% decrease. The company also saw a substantial improvement in profitability, with a 29.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Highsky Medicare?
In 2021, Highsky Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uniark Healthcare Private LimitedActive 8 years 4 monthsPerdeep Singhal and Sudhir Singal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Highsky Medicare?
Unlock and access historical data on people associated with Highsky Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Highsky Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Highsky Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
